Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
05/2011
05/25/2011CN102071181A Method for preparing alkali protease from serratieae and special culture medium thereof
05/25/2011CN102071180A New process for preparing pineapple bromelain
05/25/2011CN102071179A Method for producing cellulase through submerged fermentation of aspergillus niger liquid
05/25/2011CN102071178A Preparation method of high yield alkali pectinase
05/25/2011CN102071177A Novel preparation method for trehalase serving as pesticide target enzyme
05/25/2011CN102071176A Novel preparation method for alkaline lipase
05/25/2011CN102071175A Preparation method of transglutaminase
05/25/2011CN102071174A (2R, 3R)-2,3-butanediol dehydrogenase and coding gene and application thereof
05/25/2011CN102071173A Multi-enzyme preparation capable of effectively reducing malt and beer turbidity
05/25/2011CN102071172A Complex enzyme preparation capable of effectively reducing germination time of barley
05/25/2011CN102071171A Bifunctional glutathione synthetase and method for producing glutathione by using same
05/25/2011CN102071156A Bacillus licheniformis capable of producing beta-mannanase
05/25/2011CN102070148A Synthesis method and application of mono-disperse micron-scale spherical mesoporous silicon oxide MCM-41
05/25/2011CN101591628B Acinetobacter juni. X8 and application thereof in preparing algin lyase
05/25/2011CN101550419B Acacia AmCesA2 gene and method for improving plant cellulose content
05/25/2011CN101457229B Resistance gene ilvBN of acetohydroxyacid synthase inhibitor herbicides
05/25/2011CN101451126B Uridine diphosphate-4-one-6-deoxyglucose heterogeneous reductase and coding gene thereof and application
05/25/2011CN101260369B Mucor rouxii and method for producing xylanase by using the same
05/25/2011CN101215533B Hydantoinase and carbamoyl hydrolase producing strain, bienzyme gene and application thereof for preparing L-amino acid
05/24/2011US7947873 Compositions and methods for regulation of plant gamma-tocopherol methyltransferase
05/24/2011US7947868 Precise breeding—marker-free transformation
05/24/2011US7947819 B-raf polynucleotides
05/24/2011US7947481 Chondroitin synthase, method for producing the same and method for producing saccharide chain-extended chondroitin
05/24/2011US7947480 Everninomicin biosynthetic genes
05/24/2011US7947479 Bardet-Biedl susceptibility gene and uses thereof
05/24/2011US7947281 Chimeric proteins that induce effects directed against viruses
05/24/2011US7947270 Using multifunctional enzyme having chymotrypsin, trypsin, elastase, collagenase and/or exopeptidase activity
05/24/2011CA2549985C Formulations and methods for denaturing proteins
05/24/2011CA2453571C Vascular tissue preferred promoters
05/24/2011CA2453001C Method of testing a mammal for its predisposition for fat content of milk and/or its predisposition for meat marbling
05/24/2011CA2434059C Constitutive promoter from arabidopsis
05/24/2011CA2385266C Novel cell cycle checkpoint genes and proteins encoded thereby
05/24/2011CA2380616C Process for the biological production of 1,3-propanediol with high titer
05/24/2011CA2303428C .alpha.-ketoamide multicatalytic protease inhibitors
05/24/2011CA2247067C Meltrins
05/24/2011CA2214116C Novel endoglucanases
05/19/2011WO2011059740A1 Polypeptides having cellobiohydrolase activity and polynucleotides encoding same
05/19/2011WO2011058767A1 Firefly luciferase and gene thereof, and process for production of firefly luciferase
05/19/2011WO2011058105A1 A brewing method
05/19/2011WO2011058080A1 Anti-trypanosomiasis vaccines and diagnostics
05/19/2011WO2011057820A2 Whole cell biocatalyst
05/19/2011WO2011057397A1 Methods for treating or preventing heart damage with integrin-linked kinase (ilk) compositions
05/19/2011WO2011012697A3 Mutant yqhd enzyme for the production of a biochemical by fermentation
05/19/2011WO2011002220A3 Preparation method of lactate polymers and lactate copolymers using polyhydroxyalkanoate synthase mutants
05/19/2011WO2010118007A9 Enhanced cellulase expression in s. degradans
05/19/2011WO2010111686A3 Labeled enzyme compositions, methods & systems
05/19/2011WO2010110599A3 Novel αlpha-neoagarobiose hydrolase, and method for obtaining a monosaccharide using same
05/19/2011US20110119787 Fructan biosynthetic enzymes
05/19/2011US20110119786 Inositol polyphosphate 2-kinase genes and uses thereof
05/19/2011US20110118434 Method for polymerising glycolic acid with microorganisms
05/19/2011US20110118282 Soluble Guanylate Cyclase Activators
05/19/2011US20110118271 Kinase Inhibitors Useful For The Treatment Of Proliferative Diseases
05/19/2011US20110118255 PYRAZOLO[1,5-a]PYRIMIDINES USEFUL AS JAK2 INHIBITORS
05/19/2011US20110118177 Biotechnological production of cyanophycin dipeptides
05/19/2011US20110118140 Methods for identification, and compounds useful for the treatment of degenerative & inflammatory diseases
05/19/2011US20110117626 Hydrophobic Interaction Chromatography Membranes, and Methods of Use Thereof
05/19/2011US20110117625 Engineered Nucleases and Their Uses for Nucleic Acid Assembly
05/19/2011US20110117624 Proteases and variants thereof
05/19/2011US20110117621 Aldehyde Tags, Uses Thereof in Site-Specific Protein Modification
05/19/2011US20110117611 Nucleotide Sequences Which Code for the tal Gene
05/19/2011US20110117610 Modified Dicer Polypeptide and Methods of Use Thereof
05/19/2011US20110117608 Double-stranded nucleic acid
05/19/2011US20110117606 NRPS-PKS Gene Cluster and its Manipulation and Utility
05/19/2011US20110117598 Enhanced Protein Production in Bacillus
05/19/2011US20110117573 Cell division marker
05/19/2011US20110117084 Vandetanib derivatives
05/19/2011US20110117079 Therapeutic dll4 binding proteins
05/19/2011US20110117073 Protein Kinase Conjugates and Inhibitors
05/19/2011US20110117072 Hyperactive variants of the transposase protein of the transposon system sleeping beauty
05/19/2011US20110117065 Compositions and methods for using cells to treat heart tissue
05/19/2011US20110117011 Neutralizing proprotein convertase subtilisin kexin type 9 (pcsk9) variants and uses thereof
05/19/2011CA2780518A1 Whole cell biocatalyst
05/19/2011CA2779293A1 Solution assay and high through-put screen to probe interaction between human cullin-ring ligase complex and hiv-vif protein
05/19/2011CA2779076A1 Anti-trypanosomiasis vaccines and diagnostics
05/19/2011CA2778839A1 Glycosyl transferase from chinese hamster and related methods
05/19/2011CA2776336A1 Polypeptides having cellobiohydrolase activity and polynucleotides encoding same
05/18/2011EP2322644A1 Methods for producing modified glycoproteins
05/18/2011EP2322643A1 Aldolases, nucleic acids encoding them and methods for making and using them
05/18/2011EP2322636A1 Alpha galactosidase attached to an ER retention signal and its production in plants
05/18/2011EP2322631A1 In vivo incorporation of unnatural amino acids
05/18/2011EP2322630A2 Polypeptides having xylanase activity and polynucleotides encoding same
05/18/2011EP2322629A2 Novel glyphosate-n-acetyltransferase (GAT) genes
05/18/2011EP2322628A2 Mutations in the BCR-ABL tyrosine kinase associated with resistance to STI-571
05/18/2011EP2322627A2 Mutations in the BCR-abl tyrosine kinase associated with resistance to STI-571
05/18/2011EP2322614A1 Recombinational cloning using engineered recombination sites
05/18/2011EP2322607A1 Novel variant hyprocrea jecorina CBH1 cellulases
05/18/2011EP2322606A1 Novel variant Hyprocrea jecorina CBH1 cellulases
05/18/2011EP2322605A2 Terpene synthases
05/18/2011EP2322561A1 Anti-NIK antibodies and uses thereof
05/18/2011EP2322542A1 Reproductive ablation constructs
05/18/2011EP2322540A1 Lactobacillus acidophilus nucleic acids encoding fructo-oligosaccharide utilization compounds and uses thereof
05/18/2011EP2322229A2 Remodelling and glycoconjugation of Granulocyte Colony Stimulating Factor (G-CSF)
05/18/2011EP2322203A2 Compositions and methods for the treatment of immune related diseases
05/18/2011EP2322202A2 Compositions and methods for the treatment of immune diseases
05/18/2011EP2322201A2 Compositions and methods for the treatment of immune related diseases
05/18/2011EP2322200A2 Compositions and methods for the treatment of immune related diseases
05/18/2011EP2322193A1 Xanthine oxidase inhibitor and uric acid production inhibitor
05/18/2011EP2322154A2 Methods for detecting and clearing cross beta structure comprising proteins with crossbeta structure binding compounds.
05/18/2011EP2321409A1 New endolysin plyp40
05/18/2011EP2089433B1 Therapy targeting cathepsin s